Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms


Visceral Leishmaniasis topics
Visceral Leishmaniasis
Nucleic Acid
Pharmaceutical Formulations
Pharmaceutical Formulation

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents


Visceral Leishmaniasis patents

This page is updated frequently with new Visceral Leishmaniasis-related patent applications. Subscribe to the Visceral Leishmaniasis RSS feed to automatically get the update: related Visceral RSS feeds. RSS updates for this page: Visceral Leishmaniasis RSS RSS

Date/App# patent app List of recent Visceral Leishmaniasis-related patents
 Vaccine composition and immunization method patent thumbnailVaccine composition and immunization method
The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant a2 protein and saponin, monophosphoryl lipid a, or aluminum hydroxide plus cpg as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional elisa or immunofluorescence tests that employ antigens of promastigote forms of leishmania.. .
 Leishmaniasis antigen detection assays and vaccines patent thumbnailLeishmaniasis antigen detection assays and vaccines
The present invention relates to isolated visceral leishmaniasis (vl) antigens that are useful in therapeutic and vaccine compositions for stimulating a vl specific immunological response. The identified antigens are also useful in diagnostic assays to determine the presence of active vl in an individual.
 Leishmanicidal formulation and its use patent thumbnailLeishmanicidal formulation and its use
The present invention refers to pharmaceutical formulations obtained from the aqueous extract of the fungus agaricus blazei and its purified fractions for the treatment of leishmaniasis. More particularly, the present invention discloses formulations preferably for topic and oral use, in form of solid, semi-solid and liquid pharmaceutical formulations selected from a group consisting of gel, cream, ointment, pastes, emulsions in general, solutions, tablets and capsules for the treatment of canine and human cutaneous and visceral leishmaniasis..
 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis patent thumbnailFusion proteins and their use in the diagnosis and treatment of leishmaniasis
The present invention relates generally to a fusion protein made from a synthetic gene construct comprising of elements derived from the leishmania antigens k26, k39, and k9. The fusion protein is particularly useful in the diagnosis of leishmaniasis, particularly visceral leishmaniasis in animals such as humans and dogs..

Popular terms: [SEARCH]

Visceral Leishmaniasis topics: Visceral Leishmaniasis, Leishmaniasis, Leishmania, Polypeptide, Nucleic Acid, Antibodies, Pharmaceutical Formulations, Pharmaceutical Formulation

Follow us on Twitter
twitter icon@FreshPatents


This listing is a sample listing of patent applications related to Visceral Leishmaniasis for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Visceral Leishmaniasis with additional patents listed. Browse our RSS directory or Search for other possible listings.

Key IP Translations - Patent Translations



449989 - 0 - 4